James Hardie Industries Plc (JHX)
Australian Securities Exchange · Australia · prices in AUD · close of 22 Oct 2026
Key indicators
| Last close | AUD 36.85 |
|---|---|
| 52-week range | 24.41 – 44.12 |
| Return, 1 month / 3 months | −0.5% / +5.7% |
| Return, 1 year / 3 years | +10.3% / −6.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 49 |
| Volatility (1 year) | 42.3% |
| Worst drawdown (1 year) | -30.1% |
| Average daily value traded | 61.70M AUD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
James Hardie Industries makes fibre cement and fibre gypsum building materials used in residential and commercial construction. Its products include exterior siding, cladding, trim, soffits and backerboard, sold under brands such as HardiePlank and HardiePanel. Customers are builders, contractors, distributors and homeowners, with the United States as its main market alongside Australia, New Zealand and Europe. The company is incorporated in Ireland and maintains operations across those regions.
James Hardie Industries Plc trades under the code JHX on the Australian Securities Exchange in Australia, with its price quoted in Australian dollars (AUD). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
James Hardie Industries Plc (JHX) trades on the Australian Securities Exchange in Australia. It last closed at AUD 36.85 on 22 October 2026.
Its price-based Market X-Ray is 85 out of 100 (a strong price profile), ranking 32 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.3% and over the last three months it rose 5.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.1% | ||
| From 52-week high | -16.0% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 5.7% | ||
| 6-month return | 19.9% | ||
| 12-month return, skipping the last month | 10.8% | ||
| Stability (higher is calmer) | 80 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 42.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -30.1% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 61.70M AUD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +3.9% |
|---|---|
| 1 month | −0.5% |
| 3 months | +5.7% |
| 6 months | +19.9% |
| 1 year | +10.3% |
| 3 years | −6.5% |
| 5 years | −28.1% |
Signals
| 50-day / 200-day average | 38.81 / 34.41 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.97 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2022 | EUR 0.4317 |
| 18 Nov 2021 | EUR 0.5756 |
| 18 Feb 2021 | EUR 1.0073 |
| 15 Nov 2019 | EUR 0.1468 |
| 5 Jun 2019 | EUR 0.3728 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.